Ranoxyl is a medicine containing the active ingredient(s) ranitidine. On this page you will find out more about Ranoxyl, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: ranitidine
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Ranoxyl 150 mg film-coated tablet, 20
Consumer Medicine Information leaflet:
No consumer medicine information leaflet was found for the pack size you selected. It may be unavailable or there may be a technical problem. You should speak to your pharmacist, healthcare professional, or call healthdirect on 1800 022 222 for more information.
What this medicine is for
Indicated for short-term treatment of proven duodenal ulcer and gastric ulcer. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. Treatment of gastrinoma (Zollinger-Ellison syndrome). Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative antireflux measures and simple drug therapies such as antacids. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. Treatment of scleroderma oesophagitis.
Table of characteristics
|Visual appearance||CREAMISH-YELLOW, ROUND BICONVEX, FILM-COATED TABLETS PRINTED WITH 'RAN 150' IN BLACK ON ONE SIDE.|
|Dosage Form||Tablet, film coated|
|Route of administration||Oral|
360 tablets( for dispensing only): Prescription Only Medicine, or Prescription Animal Remedy
60 tablets: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||No information available|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
Ranoxyl | myVMC
Ranoxyl is a treatment for peptic ulcer disease, gastro-oesophageal reflux disease (GORD) and dyspepsia. It contains the H2 receptor blocker ranitidine.
Read more on myVMC – Virtual Medical Centre website
Hiatus hernia: diagnosis and treatment - myDr.com.au
Hiatus hernia is often diagnosed when doctors investigate reflux with an endoscopy or barium X-ray. The hiatus hernia can show up as a bulge positioned between the oesophagus and your stomach.
Read more on myDr website
Found 0 results